Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

RENAL TREATMENT CENTERS-ILLINOIS INC

NPI: 1588042857 · PONTIAC, MI 48341 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/07/2015

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more

$1.85M
Total Medicaid Paid
29,240
Total Claims
3,444
Beneficiaries
14
Codes Billed
2018-01
First Month
2024-09
Last Month

Provider Details

Authorized OfficialWINSTEL, JOHN (CHIEF ACCOUNTING OFFICER)
NPI Enumeration Date05/07/2015

Related Entities

Other providers sharing the same authorized official: WINSTEL, JOHN

ProviderCityStateTotal Paid
TOTAL RENAL CARE INC INGLEWOOD CA $22.54M
TOTAL RENAL CARE INC MIAMI FL $16.77M
DVA HEALTHCARE RENAL CARE INC LOS ANGELES CA $14.01M
DVA HEALTHCARE RENAL CARE INC BURBANK CA $10.72M
DVA HEALTHCARE RENAL CARE INC OAKLAND CA $10.67M
DVA HEALTHCARE RENAL CARE INC WESTMINSTER CA $8.32M
DVA HEALTHCARE RENAL CARE INC APPLE VALLEY CA $6.93M
DVA HEALTHCARE RENAL CARE INC GLENDALE CA $5.32M
RENAL TREATMENT CENTERS CALIFORNIA INC SANTA ANA CA $5.08M
DVA HEALTHCARE RENAL CARE INC BERKELEY CA $4.25M
TOTAL RENAL CARE INC PLANTATION FL $4.08M
DVA RENAL HEALTHCARE INC LOS ANGELES CA $4.01M
DVA HEALTHCARE OF MASSACHUSETTS INC SALEM MA $3.57M
DVA RENAL HEALTHCARE INC SIERRA VISTA AZ $3.52M
RENAL TREATMENT CENTERS-SOUTHEAST, LP. PANAMA CITY FL $3.14M
WESTON DIALYSIS CENTER LLC WESTON FL $3.01M
BEVERLY HILLS DIALYSIS PARTNERSHIP BEVERLY HILLS CA $2.90M
RENAL TREATMENT CENTERS CALIFORNIA INC EL MONTE CA $2.82M
TOTAL RENAL CARE INC ANTIOCH CA $2.72M
DVA HEALTHCARE RENAL CARE INC PHILADELPHIA PA $2.30M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 8,828 $710K
2019 9,030 $475K
2020 6,412 $294K
2021 2,658 $116K
2022 1,179 $89K
2023 572 $84K
2024 561 $82K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
90999 Unlisted dialysis procedure, inpatient or outpatient 12,295 1,153 $1.81M
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) 10,733 759 $43K
83970 27 25 $3.90
85041 84 82 $1.70
85048 84 82 $1.43
82728 124 119 $1.29
83550 126 119 $0.83
83540 113 107 $0.61
A4657 Syringe, with or without needle, each 769 326 $0.04
J1756 Injection, iron sucrose, 1 mg 1,696 367 $0.00
82108 13 12 $0.00
J1270 Injection, doxercalciferol, 1 mcg 3,149 269 $0.00
90674 13 12 $0.00
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result 14 12 $0.00